Provider Statement

This continuing medical education activity is provided by

Support Statement

This activity is supported by an educational grant from Genentech, Inc.


Paul W. Noble, MD
Professor and Chair, Department of Medicine
Director, Women's Guild Lung Institute
Cedars-Sinai Medical Center
Los Angeles, CA

Consulting Fees: Boehringer-Ingelheim, GlaxoSmithKline, Moerae Matrix, Roche-Genentech


Amy L. Olson, MD, MSPH

Speakers Bureau: Boehringer-Ingelheim
Fees for Non-CME Services: Boehringer-Ingelheim, Genentech
Contracted Research: United Therapeutics

Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP

No relevant financial relationships to disclose.

Vindico Medical Education staff have no relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Activity Details

Credit Type: AMA PRA Category 1 Credit
Credit Amount: 0.75 credit hour
Release Date: December 14, 2016
Expiration Date: December 14, 2017
Estimated Time to Complete Activity: 45 minutes
Registration Required: No
Fee for Activity: There is no fee for participating in this activity.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears above.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, December 14, 2016 to December 14, 2017.

How To Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the virtual poster presentation, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


Diffuse interstitial lung disease (ILD) is an umbrella term that comprises a broad range of related conditions, causing shortness of breath and cough. Idiopathic pulmonary fibrosis (IPF), is a chronic, progressive, fibrotic lung disease of unknown cause and is associated with comorbidities, including pulmonary hypertension. The historical standard of care for IPF is oxygen supplementation, management of comorbidities, and lung transplantation. The therapeutic landscape for IPF management has evolved with the US Food and Drug Administration’s approval of 2 novel therapeutic agents. This digital poster hall CME activity will feature expert commentary of select abstracts from the 2016 American Thoracic Society International Conference, focusing on recent advances in the management of ILD.

Target Audience

The intended audience for the activity is pulmonologists and other health care professionals involved in the treatment of patients with ILD.

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Apply recent advances in the management of interstitial lung diseases to practice to improve patient health and outcomes.
  • Implement therapeutic regimens that reflect state-of-the-science clinical advances in safety and efficacy of available therapies for the management of interstitial lung diseases.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.